U.S. Markets closed

Detailed Research: Economic Perspectives on Genocea Biosciences, Big Lots, SemGroup, Conn's, Mimecast, and Neos Therapeutics — What Drives Growth in Today's Competitive Landscape

NEW YORK, Nov. 27, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Genocea Biosciences, Inc. (GNCA), Big Lots, Inc. (BIG), SemGroup Corporation (SEMG), Conn's, Inc. (CONN), Mimecast Limited (MIME), and Neos Therapeutics, Inc. (NEOS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

GNCA DOWNLOAD: http://MarketSourceResearch.com/register/?so=GNCA
BIG DOWNLOAD: http://MarketSourceResearch.com/register/?so=BIG
SEMG DOWNLOAD: http://MarketSourceResearch.com/register/?so=SEMG
CONN DOWNLOAD: http://MarketSourceResearch.com/register/?so=CONN
MIME DOWNLOAD: http://MarketSourceResearch.com/register/?so=MIME
NEOS DOWNLOAD: http://MarketSourceResearch.com/register/?so=NEOS

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Genocea Biosciences, Inc. (GNCA), Big Lots, Inc. (BIG), SemGroup Corporation (SEMG), Conn's, Inc. (CONN), Mimecast Limited (MIME), and Neos Therapeutics, Inc. (NEOS) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 23rd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

GENOCEA BIOSCIENCES, INC. (GNCA) REPORT OVERVIEW

Genocea Biosciences' Recent Financial Performance

For the twelve months ended December 31st, 2017 vs December 31st, 2016, Genocea Biosciences reported revenue of $0.00MM vs $0.24MM and analysts estimated basic earnings per share -$1.98 vs -$1.75. Analysts expect earnings to be released on February 21st, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.37. The estimated EPS forecast for the next fiscal year is -$0.57 and is expected to report on February 21st, 2019.

To read the full Genocea Biosciences, Inc. (GNCA) report, download it here: http://MarketSourceResearch.com/register/?so=GNCA

-----------------------------------------

BIG LOTS, INC. (BIG) REPORT OVERVIEW

Big Lots' Recent Financial Performance

For the three months ended July 31st, 2018 vs July 31st, 2017, Big Lots reported revenue of $1,222.17MM vs $1,219.60MM (up 0.21%) and analysts estimated basic earnings per share $0.59 vs $0.68 (down 13.24%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Big Lots reported revenue of $5,270.98MM vs $5,200.44MM (up 1.36%) and analysts estimated basic earnings per share $4.43 vs $3.37 (up 31.45%). Analysts expect earnings to be released on December 7th, 2018. The report will be for the fiscal period ending October 31st, 2018. Reported EPS for the same quarter last year was $0.06. The estimated EPS forecast for the next fiscal year is $4.78 and is expected to report on March 8th, 2019.

To read the full Big Lots, Inc. (BIG) report, download it here: http://MarketSourceResearch.com/register/?so=BIG

-----------------------------------------

SEMGROUP CORPORATION (SEMG) REPORT OVERVIEW

SemGroup's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, SemGroup reported revenue of $634.00MM vs $545.92MM (up 16.13%) and analysts estimated basic earnings per share $0.03 vs -$0.25. For the twelve months ended December 31st, 2017 vs December 31st, 2016, SemGroup reported revenue of $2,081.92MM vs $1,332.16MM (up 56.28%) and analysts estimated basic earnings per share -$0.24 vs $0.04. Analysts expect earnings to be released on February 25th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.03. The estimated EPS forecast for the next fiscal year is $0.59 and is expected to report on February 25th, 2019.

To read the full SemGroup Corporation (SEMG) report, download it here: http://MarketSourceResearch.com/register/?so=SEMG

-----------------------------------------

CONN'S, INC. (CONN) REPORT OVERVIEW

Conn's' Recent Financial Performance

For the three months ended July 31st, 2018 vs July 31st, 2017, Conn's reported revenue of $384.62MM vs $366.65MM (up 4.90%) and basic earnings per share $0.54 vs $0.14 (up 285.71%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Conn's reported revenue of $1,516.03MM vs $1,596.85MM (down 5.06%) and analysts estimated basic earnings per share $0.21 vs -$0.83. Analysts expect earnings to be released on December 6th, 2018. The report will be for the fiscal period ending October 31st, 2018. The reported EPS for the same quarter last year was $0.18. The estimated EPS forecast for the next fiscal year is $3.14 and is expected to report on April 4th, 2019.

To read the full Conn's, Inc. (CONN) report, download it here: http://MarketSourceResearch.com/register/?so=CONN

-----------------------------------------

MIMECAST LIMITED (MIME) REPORT OVERVIEW

Mimecast's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Mimecast reported revenue of $82.17MM vs $63.07MM (up 30.29%) and analysts estimated basic earnings per share -$0.03 vs -$0.02. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Mimecast reported revenue of $261.90MM vs $186.56MM (up 40.38%) and analysts estimated basic earnings per share -$0.22 vs -$0.10. Analysts expect earnings to be released on February 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.05. The estimated EPS forecast for the next fiscal year is $0.16 and is expected to report on May 13th, 2019.

To read the full Mimecast Limited (MIME) report, download it here: http://MarketSourceResearch.com/register/?so=MIME

-----------------------------------------

NEOS THERAPEUTICS, INC. (NEOS) REPORT OVERVIEW

Neos Therapeutics' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Neos Therapeutics reported revenue of $12.50MM vs $7.10MM (up 76.10%) and analysts estimated basic earnings per share -$0.43 vs -$0.58. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Neos Therapeutics reported revenue of $25.02MM vs $9.15MM (up 173.30%) and analysts estimated basic earnings per share -$2.68 vs -$5.19. Analysts expect earnings to be released on March 21st, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.49. The estimated EPS forecast for the next fiscal year is -$0.71 and is expected to report on March 21st, 2019.

To read the full Neos Therapeutics, Inc. (NEOS) report, download it here: http://MarketSourceResearch.com/register/?so=NEOS

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.